Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma

Journal of the American College of Surgeons

Volumn 201, Issue 1, 2005, Pages 37-47

  Sabel, Michael S ^a   Griffith, Kent ^b   Sondak, Vernon K ^a   Lowe, Lori ^a   Schwartz, Jennifer L ^a   Cimmino, Vincent M ^a   Chang, Alfred E ^a   Rees, Riley S ^a   Bradford, Carol R ^a   Johnson, Timothy M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; SCHOOL CHILD; SENTINEL LYMPH NODE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FORECASTING; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SEX FACTORS; SKIN NEOPLASMS;

EID: 20544433657     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2005.03.029     Document Type: Article

References (30)

1. J.E. Gershenwald, W. Thompson, P.F. Mansfield Multi-institutional melanoma lymphatic mapping experience the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol 17 1999 976 983
2. D.L. Morton, J.F. Thompson, R. Essner Multicenter Selective Lymphadenectomy Trial Group Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma a multicenter trial Ann Surg 230 1999 453 463
3. B.S. Cherpelis, F. Haddad, J. Messina Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas J Am Acad Dermatol 44 2001 762 766
4. J.F. Thompson, R.F. Uren, H.M. Shaw Location of sentinel lymph nodes in patients with cutaneous melanoma new insights into lymphatic anatomy J Am Coll Surg 189 1999 195 204
5. D.L. Morton, D.R. Wen, J.H. Wong Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 1992 392 399
6. K.M. McMasters, D.S. Reintgen, M.I. Ross Sentinel lymph node biopsy for melanoma controversy despite widespread agreement J Clin Oncol 19 2001 2851 2855
7. N. Cascinelli, F. Belli, M. Santinami Sentinel lymph node biopsy in cutaneous melanoma the WHO Melanoma Program experience Ann Surg Oncol 7 2000 469 474
8. K.M. McMasters, S.L. Wong, M.J. Edwards Frequency of nonsentinel lymph node metastasis in melanoma Ann Surg Oncol 9 2002 137 141
9. M.E. Reeves, R. Delgado, K.J. Busam Prediction of nonsentinel lymph node status in melanoma Ann Surg Oncol 10 2003 27 31
10. J.D. Wagner, M.S. Gordon, T.Y. Chuang Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma Cancer 89 2000 453 462
11. N. Elias, K.K. Tanabe, A.J. Sober Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary Arch Surg 139 2004 400 405
12. M.F. Azzola, H.M. Shaw, J.F. Thompson Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma an analysis of 3661 patients from a single center Cancer 97 2003 1488 1498
13. V.K. Sondak, J.M. Taylor, M.S. Sabel Mitotic rate and younger age are predictors of sentinel lymph node positivity lessons learned from the generation of a probabilistic model Ann Surg Oncol 11 2004 247 258
14. D.J. Karimipour, L. Lowe, L. Su Standard immunostains for melanoma in sentinel lymph node specimens which ones are most useful? J Am Acad Dermotol 50 2003 759 764
15. M.S. Pepe The statistical evaluation of medical tests for classification and prediction 2003 Oxford University Press New York
16. E. Joseph, A. Brobeil, F. Glass Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes Ann Surg Oncol 5 1998 119 125
17. B.M. Clary, M.S. Brady, J.J. Lewis, D.G. Coit Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma review of a large single-institutional experience with an emphasis on recurrence Ann Surg 233 2001 250 258
18. J.D. Wagner, M.S. Gordon, T.-Y. Chuang Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma Cancer 89 2000 453 462
19. A.J. Cochran, D.-R. Wen, R.-R. Huang Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node Mod Pathol 17 2004 747 755
20. J.F. Thompson, W.H. McCarthy, C.M. Bosch Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes Melanoma Res 5 1995 255 260
21. R. Essner, A. Conforti, M.C. Kelley Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma Ann Surg Oncol 6 1999 442 449
22. R.J.C.L.M. Vuylsteke, P.A.M. van Leeuwen, M.G.S. Muller Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection long-term follow-up results J Clin Oncol 21 2003 1057 1065
23. C.M. Balch, S.-J. Soong, A.A. Bartolucci Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger Ann Surg 224 1996 255 266
24. C.M. Balch, S.-J. Soong, M.I. Ross Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm) Ann Surg Oncol 7 2000 87 97
25. N. Cascinelli, A. Morabito, M. Santinami Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk a randomized trial Lancet 351 1998 793 796
26. A.C. Degnim, K.A. Griffith, M.S. Sabel Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma Cancer 98 2003 2307 2315
27. A.J. Cochran, D.R. Wen, H.R. Herschman Occult melanoma in lymph nodes detected by antiserum to S-100 protein Int J Cancer 34 1984 159 163
28. P.J. Bostick, D.L. Morton, R.R. Turner Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase- polymerase chain reaction in early-stage melanoma patients J Clin Oncol 17 1999 3238 3244
29. J.H. Lee, R. Essner, H. Torisu-Itakura Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma J Clin Oncol 22 2004 3677 3684
30. H.A. Gietema, R.J.C.L.M. Vuylsteke, P.J. van Diest Predicting nonsentinel lymph node involvement in stage I/II melanoma [letter] Ann Surg Oncol 10 2003 993 author reply 993-994